U.S. flag

An official website of the United States government

NM_001905.4(CTPS1):c.1692-1G>C AND Severe combined immunodeficiency due to CTPS1 deficiency

Germline classification:
Pathogenic (5 submissions)
Last evaluated:
Jan 14, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000128633.17

Allele description [Variation Report for NM_001905.4(CTPS1):c.1692-1G>C]

NM_001905.4(CTPS1):c.1692-1G>C

Gene:
CTPS1:CTP synthase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p34.2
Genomic location:
Preferred name:
NM_001905.4(CTPS1):c.1692-1G>C
HGVS:
  • NC_000001.11:g.41010160G>C
  • NG_034208.1:g.35862G>C
  • NM_001301237.2:c.1224-1G>C
  • NM_001905.4:c.1692-1G>CMANE SELECT
  • LRG_1229t1:c.1692-1G>C
  • LRG_1229:g.35862G>C
  • NC_000001.10:g.41475832G>C
  • NM_001905.2:c.1692-1G>C
  • NM_001905.3:c.1692-1G>C
Nucleotide change:
IVS17, G-C, -1 (rs145092287)
Links:
OMIM: 123860.0001; dbSNP: rs145092287
NCBI 1000 Genomes Browser:
rs145092287
Molecular consequence:
  • NM_001301237.2:c.1224-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001905.4:c.1692-1G>C - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Name:
Severe combined immunodeficiency due to CTPS1 deficiency
Synonyms:
Immunodeficiency 24
Identifiers:
MONDO: MONDO:0014391; MedGen: C4014617; Orphanet: 420573; OMIM: 615897

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000172268OMIM
no assertion criteria provided
Pathogenic
(Jun 12, 2014)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000774175Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 14, 2024)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV000926210Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust
no assertion criteria provided
Pathogenic
(May 3, 2019)
inheritedclinical testing

SCV001522698Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jul 12, 2019)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001760030Genomics England Pilot Project, Genomics England
no assertion criteria provided

(ACGS Guidelines, 2016)
Pathogenicgermlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedinheritedyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

CTP Synthase 1 Deficiency in Successfully Transplanted Siblings with Combined Immune Deficiency and Chronic Active EBV Infection.

Kucuk ZY, Zhang K, Filipovich L, Bleesing JJ.

J Clin Immunol. 2016 Nov;36(8):750-753. Epub 2016 Sep 14. No abstract available.

PubMed [citation]
PMID:
27638562

Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation.

Martin E, Minet N, Boschat AC, Sanquer S, Sobrino S, Lenoir C, de Villartay JP, Leite-de-Moraes M, Picard C, Soudais C, Bourne T, Hambleton S, Hughes SM, Wynn RF, Briggs TA; Genomics England Research Consortium, Patel S, Lawrence MG, Fischer A, Arkwright PD, Latour S.

JCI Insight. 2020 Mar 12;5(5). doi:pii: 133880. 10.1172/jci.insight.133880.

PubMed [citation]
PMID:
32161190
PMCID:
PMC7141395
See all PubMed Citations (7)

Details of each submission

From OMIM, SCV000172268.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 8 children from 5 families from the northwest region of England who manifested a combined deficiency of adaptive immunity (IMD24; 615897), Martin et al. (2014) detected a homozygous G-to-C transversion at the -1 position of intron 17 of the CTPS1 gene (rs145092287) using whole-exome and confirmatory Sanger sequencing. The authors referred to the mutation as IVS18-1G-C and noted its genomic location as position 41475832 on chromosome 1. The mutation resulted in expression of an abnormal transcript lacking exon 18. The mutation was considered deleterious since CTPS1 protein expression could not be detected in lysates of EBV-transformed B cells and T-cell blasts from patients. All parents and unaffected sibs tested were heterozygous carriers. Sequencing of a cohort of 752 healthy individuals from the northwest of England gave an estimated frequency of homozygosity of 1 in 560,000. This frequency represented a more than 10-fold increase compared to the frequency estimated from available exome databases. Whole-exome sequencing data and analysis of polymorphic microsatellite markers in all patients revealed a common region of homozygosity of 1.1 Mb surrounding the mutation. These data indicated a founder effect.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000774175.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change affects an acceptor splice site in intron 17 of the CTPS1 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. This variant is present in population databases (rs145092287, gnomAD 0.02%). Disruption of this splice site has been observed in individual(s) with combined immunodeficiency (PMID: 24870241, 27638562, 32161190). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 140454). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that disruption of this splice site alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 24870241). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Oxford Medical Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, SCV000926210.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1inheritedyesnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV001522698.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

From Genomics England Pilot Project, Genomics England, SCV001760030.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024